EUCTR2010-022820-61-IT进行中（未招募）不适用
PHASE CONTRAST MAGNETIC RESONANCE (MR) IMAGING IN MONITORING THE EFFECTS OF TADALAFIL IN PATIENTS WITH OUT-OF-PROPORTION PULMONARY HYPERTENSION AND LEFT VENTRICULAR DYSFUNCTION - ND
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA0 个研究点开始时间: 2010年12月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •patients aged > 18 yrs with out-of-proportion hypertension associated to moderate left ventricular dysfunction (a subgroup of the 2? category of the WHO clinical classification system Venice 2003 ervision) NYHA class IIa referred to pulmonary hypertension center for evaluation. - moderate left ventricular dysfunction is defined as left ventricular ejection fraction between 35 and 45% - pulmonary hypertension out-of-proportion associated to left ventricular dysfunction is defined as mean mean pulmonary arterial pressure (PAP = 40-45 mmHg and a transpulmonary pressure gradient (mean PAP- mean pulmonary wedge pressure –PWP) > 12 mmHg (ESC-ERS Guidelines 2009)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Exclusion criteria will be idiopatic pulmonary hypertension and pulmonary hypertension secondary to chronic obstructive or restrictive pulmonary disease, recurrent pulmonary embolism, pulmonary venous congestion, acute or chronic inflammatory lung disease, pregnancy or insufficient contraceptive measures, and previous treatment with PDE inhibitors and contraindication to assumption of PDE5i (patients with hepatic or renal insufficiency and known retinal disease) and concomitant use of nitrate. Hypersensitivity to the active substance or to any of the excipients. Acute myocardial infarction within the last 90 days. Severe hypotension (<90/50 mm Hg). Patients who have loss of vision in one eye because of non-arteritic anterior ischemic optic neuropathy (NAION), regardless of whether this episode was in connection or not with previous PDE5 inhibitor exposure. Patients with clinically significant aortic and mitral valve disease. Patients with pericardial constriction. Patients with restrictive or congestive cardiomyopathy . Patients with significant left ventricular dysfunction. Patients with life-threatening arrhythmias. Patients with symptomatic coronary artery disease . Patients with uncontrolled hypertension. Pulmonary veno-occlusive disease (PVOD). Patients with severe hepatic cirrhosis (Child-Pugh Class C) have not been studied and therefore dosing. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption.
研究者
相似试验
已完成
不适用
Contrast enhanced Magnetic Resonance Imaging of the lungs in children with Cystic Fibrosis.10038716mucoviscoidosisNL-OMON31207Erasmus MC, Universitair Medisch Centrum Rotterdam30
已完成
不适用
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Study for Biochemocal Failures after Radical ProstatectomyProstate cancerJPRN-UMIN000009823The University of Tokyo Hospital50
已完成
不适用
Dynamic Contrast Enhanced Magnetic Resonance Imaging Parameters after Radiotherapy for Bone Metastases in Patients with Hepatocellular Carcinoma : A Prospective StudyDiseases of the musculo-skeletal system and connective tissueKCT0004861Samsung Medical Center14
尚未招募
不适用
Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) in predicting Chemoradiation Sensitive Nasopharyngeal Carcinoma and Plasma Epstein-Barr virus (EBV) levelasopharyngeal carcinomaDynamic contrast enhanced magnetic resonance imagingPerfusionNasopharyngeal carcinomaTCTR20180227002none40
进行中（未招募）
不适用
MRI contrast agent in the spinal canal of adults with cerebrospinal fluid circulation disordersCerebrospinal fluid circulation disorder seen in the following clinical disease states: Communicating hydrocephalus, idiopathic intracranial hypertension, idiopathic intracranial hypotension, intracranial cysts (cerebral cysts and arachnoid cysts).EUCTR2015-001673-40-NOOslo University Hospital